Sanofi launches DE&I Board

Sanofi introduces its Diversity, Equity & Inclusion (DE&I) Board, the first board to feature outside advisors within the pharmaceutical industry 

Sanofi introduces the first-of-its kind Diversity, Equity & Inclusion (DE&I) Board to feature outside advisors. Sanofi’s DE&I Board will include three of the most prominent voices in the field: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Rohini Anand.

With a focus on building representative leadership, creating a work environment in which employees can bring their whole selves and engaging with Sanofi’s diverse communities, the DE&I strategy was revamped in June 2021 with set objectives for 2025. The DE&I Board has the responsibility of ensuring Sanofi’s DE&I strategy is effectively implemented, monitoring progress on the company’s 2025 targets, and advising on how to accelerate the company’s impact in this area.

Follow us:

Share this article:

Share on linkedin
LinkedIn

Sign Up to our newsletter

Sign up to our newsletter to stay up to date with the latest industry news 

At Easyfairs, we take your privacy seriously and will only use the information we collect or receive about you in accordance with our privacy policy. If you change your mind you can unsubscribe at any time.